Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Lucie Vinklarova

2PUBLICATIONS
10CO-AUTHORS
Medical biochemistry - lipidsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Apr 20, 2020
Friend or enemy? Review of 17β-HSD10 and its role in human health or disease.

Lucie Vinklarova, Monika Schmidt, Ondrej Benek

|Mar 15, 2018
1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.

Ondrej Benek, Lukas Hroch, Laura Aitken

Pageof 1

Frequent Collaborators

2 joint publications

Ondrej Benek

2 joint publications

Frank Gunn-Moore

2 joint publications

Kamil Kuca

2 joint publications

Kamil Musilek

1 joint publications

Lukas Hroch

1 joint publications

Laura Aitken

1 joint publications

Daniel I Perez

1 joint publications

Concepcion Perez

1 joint publications

Ana Martinez

1 joint publications

Monika Schmidt

Frequent Collaborators

2 joint publications

Ondrej Benek

2 joint publications

Frank Gunn-Moore

2 joint publications

Kamil Kuca

2 joint publications

Kamil Musilek

Top Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on : May 10, 2016

12.6K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

1.2K
See more related videos

Top Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on : May 10, 2016

12.6K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

1.2K
See more related videos